Ovarian cancer that later spread to an axillary lymph node
This ovarian cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Sex
- Female
- Spread to
- axillary lymph nodes
- Treatment
- chemotherapy, surgery and hormone therapy
- Outcome
- Stable Disease
Treatment course, step by step
- She received 3 cycles of chemotherapy followed by debulking surgery and 6 more cycles.
- When an axillary lymph-node metastasis appeared, she received another 6 cycles of chemotherapy.
- Later peritoneal progression was treated with further chemotherapy and then an aromatase inhibitor.
What happened, in summary
A 69-year-old woman was diagnosed with advanced ovarian cancer after scans showed tumors involving both ovaries, abdominal lymph nodes, the omentum, and peritoneum. She received 3 cycles of chemotherapy, then underwent debulking surgery. Pathology showed an ovarian malignant mixed Müllerian tumor, also called ovarian carcinosarcoma, and the postoperative disease was classified as Stage III.
She completed 6 additional chemotherapy cycles and entered follow-up. More than 2 years later, imaging found an enlarged lymph node in the right armpit. Breast imaging was clear, and removal of the node confirmed that the cancer had spread there from the ovary. This distant nodal recurrence made the disease Stage IV.
She received another 6 cycles of chemotherapy, with scans showing no visible disease afterward. In 2018, however, CA-125 rose and scans found multiple new peritoneal nodules. She underwent further chemotherapy, followed by a different chemotherapy combination and then an aromatase inhibitor.
Her disease remained stable through her last recorded visit in July 2019.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- Stage 4 Ovarian Cancer 31 stories
- Chemotherapy for Ovarian Cancer 126 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer